Ipca Labs.

IPCALAB25 Apr 2024
Pharmaceuticals
-5.85 (-0.43%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Ipca Labs.
Ipca Labs.
Pharmaceuticals
IPCALAB25 Apr 2024
-5.85 (-0.43%)
1D
1M
6M
1Y
5Y
All

Ipca Labs. - Share Price & Details

Lowest Today
1336.65
Highest Today
1354
Today’s Open
1348.95
Prev. Close
1347.25
52 Week High
1374.6
52 Week Low
669.8
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
63.01%
Upper Circuit
Lower Circuit
P/E TTM
62.09
P/B Ratio
5.51
Traded Value(Cr)
0.04
EPS TTM
21.7
Book value
Dividend
0.30%

Price Performance

-0.37 %
1 Wk
12.19 %
1 M
22.65 %
3 M
63.01 %
1 Y
20.36 %
YTD

Traded Volume Movement

Technical Details

Support 3
1317
Support 2
1327
Support 1
1335
Pivot Point :
1345
Resistance 1
1352
Resistance 2
1362
Resistance 3
1369

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Ipca Laboratories Ltd
₹1,341.40(-5.85/-0.43%)
1,341.40-5.8534,180.3063.0162.095.51
Lupin Ltd
₹1,587.65(+7.65/0.48%)
1,587.65+7.6572,008.52125.0634.943.74
Alembic Pharmaceuticals Ltd
₹970.95(+12.95/1.35%)
970.95+12.9518,830.7576.0531.404.17
J B Chemicals & Pharmaceuticals Ltd
₹1,856.00(+31.45/1.72%)
1,856.00+31.4528,316.0774.4055.9310.55
Sanofi India Ltd
₹8,179.75(-4.55/-0.06%)
8,179.75-4.5518,848.4436.6431.8718.53
403.95+2.002,359.671.2913.661.48

About Ipca Laboratories Ltd

Ipca Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 34185.37 crores. It has reported a sales of Rs. 1506.83 crores and a net profit of Rs. 136.94 crores for the quarter ended December 2018. The company management includes Premchand Godha, Premchand Godha,A K Jain,Pranay Godha,Prashant Godha,Anand T Kusre,Manisha Premnath,Kamal Kishore Seth,Narendra Mairpady,Harish P Kamath (Ipca Laboratories Ltd) among others.
Chairman
Premchand Godha
Registered office
48 Kandivli Industrial Estate,Kandivli (West),Mumbai,Maharashtra,400067
FAX :91-22-28686613
Background
Incorporation Year1949
Face Value₹1
Market Lot1

Latest News

📢 Sensex plunges 213 points at the open; Nifty below 22,350
📈 Amid weak global cues, domestic benchmark indices started gap-down on April 25.
📢 At 9:16 AM, the Sensex tanked 212.95 points or 0.29% at 73,639.99, and the Nifty plunged 63.20 points or 0.28% at 22,339.20.
📊 Kotak Mahindra Bank (⬇️9.27%), LTIM (⬇️2.13%) and HUL (⬇️0.97%) appeared as the top losers on the Nifty 50 at the Open.
25 Apr 2024 | 09:24 AM
📢 Sensex plunges 213 points at the open; Nifty below 22,350
📈 Amid weak global cues, domestic benchmark indices started gap-down on April 25.
📢 At 9:16 AM, the Sensex tanked 212.95 points or 0.29% at 73,639.99, and the Nifty plunged 63.20 points or 0.28% at 22,339.20.
📊 Kotak Mahindra Bank (⬇️9.27%), LTIM (⬇️2.13%) and HUL (⬇️0.97%) appeared as the top losers on the Nifty 50 at the Open.
25 Apr 2024 | 09:24 AM
HUL share price falls after muted Q4 results
Hindustan Unilever share price declined over a percent on Thursday after the company reported its earnings for the quarter ended March 2024. HUL shares fell as much as 1.2% to ₹2,218.00 apiece on the BSE after muted Q4 results. FMCG major Hindustan Unilever reported a standalone net profit of ₹2,406 crore in Q4FY24, registering a decline of 6% from ₹2,552 crore in the same period last year.
25 Apr 2024 | 10:24 AM
Multi Commodity Exchange Of India Q4 Results
Multi Commodity Exchange Of India Q4 Results: Multi Commodity Exchange Of India declared their Q4 results on 23 Apr, 2024. The topline increased by 35.43% & the profit increased by 1512.29% YoY. As compared to the previous quarter the revenue declined by 5.42% and the profit increased by 1742.43%. The Selling, general & administrative expenses rose by 8.05% q-o-q & increased by 33.03% Y-o-Y.
25 Apr 2024 | 10:23 AM
Mukesh Ambani's JioCinema cuts premium price to nearly  ₹1/day
Mukesh Ambani's streaming platform JioCinema on April 25 announced a significant two-third reduction in prices for its premium services. JioCinema premium will now be available for as low as  ₹29 per month, in a bid to amplify the competition with streaming giants such as Netflix and Amazon Prime, Reuters reported.
25 Apr 2024 | 10:09 AM

How to buy Ipca Labs. shares on nse?

To buy Ipca Labs. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Ipca Labs. share price today?

The Ipca Labs. shares price on nse is Rs.1341.4 today.

What is the market cap of Ipca Labs. shares on NSE ?

The company has a market capitalization of Rs.34180.30Cr

What is the PE & PB ratio of Ipca Labs. shares ?

PE is 62.09 and PB is 5.51

What is the 52 Week High and Low of Ipca Labs. shares?

Ipca Labs. stock price high: Rs.1374.6 Ipca Labs. stock price low: Rs.669.8

Is Ipca Labs a government-run institution?

No, IPCA Laboratories is not a government-run organization. It is a privately-owned pharmaceutical company based in India. IPCA Laboratories was founded in 1949 and has since grown to become one of the leading pharmaceutical companies in India.

Who is Ipca Labs’ owner?

IPCA Laboratories is a publicly-traded company and its ownership is spread among its shareholders. The Promoter of IPCA Labs is Mr. Premchand Godha and his family.

How well is Ipca Labs doing?

IPCA Laboratories operates in the pharmaceutical industry and has a diverse product portfolio that includes medicines for various therapeutic segments, including antimalarials, anti-bacterial, pain management, and cardiovascular drugs.

Ipca Labs’ consolidated revenue has gone from Rs. 3773.18 crores in March 2019 to  Rs. 5,829.79 crores on 31 March 2022. The net profit has gone from Rs. 443.03 crores to Rs. 910.95 crores in the same period.

Ipca Labs stock has given a positive return of 10.05% over the past three years and a negative return of -18.57% over the past one year.

 

What are the latest results of Ipca Labs?

The last fiscal result of Ipca Labs was declared in March 2022 and they reported a consolidated revenue of INR 5,829.79 crore and net profit of Rs. 910.95 crores.

What are the potential catalysts that positively impact the stock price of Ipca lab?

Some potential catalysts that may positively affect IPCA Laboratories' stock price could include:

  • Strong financial results
  • Expansion in new markets
  • Launch of new products
  • Regulatory approvals
  • Industry trends